Myelopathy associated with SARS-COV-2 infection. A systematic review
Category
Research
-
-
Breaking newsResearchCOVID-19
Drug treatments for COVID-19: living systematic review and network meta-analysis
May 5, 2021Drug treatments for COVID-19: living systematic review and network meta-analysis -
Breaking newsResearchCOVID-19
Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study
May 5, 2021Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study -
Breaking newsResearchCOVID-19
Prevalence, clinical characteristics and outcomes of Guillain‐Barré syndrome spectrum associated with COVID‐19: a systematic review and meta‐analysis
May 5, 2021Prevalence, clinical characteristics and outcomes of Guillain‐Barré syndrome spectrum associated with COVID‐19: a systematic review and meta‐analysis -
Breaking newsResearchCOVID-19
Neuro‐COVID frequency and short‐term outcome in the northern Portuguese population
May 5, 2021Neuro‐COVID frequency and short‐term outcome in the northern Portuguese population -
Breaking newsResearchCOVID-19
Increased Incidence of Functional (Psychogenic) Movement Disorders in Children and Adults Amidst the COVID-19 Pandemic: A Cross-Sectional Study
May 5, 2021Increased Incidence of Functional (Psychogenic) Movement Disorders in Children and Adults Amidst the COVID-19 Pandemic: A Cross-Sectional Study -
Breaking newsCOVID-19Research
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
May 5, 2021Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant -
Breaking newsResearchCOVID-19
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
May 5, 2021mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection -
Breaking newsResearchCOVID-19
High-dimensional characterization of post-acute sequalae of COVID-19
May 5, 2021High-dimensional characterization of post-acute sequalae of COVID-19 -
Paper of the MonthCOVID-19
COVID-19 Paper of the month: Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
May 1, 2021For May 2021, we have selected: Rentsch CT et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ 202;372:n311. doi: 10.1136/bmj.n311. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the month: Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
May 1, 2021For May 2021, we have selected: Walgaard et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021; 20=:275-283. doi: 10.1016/S1474-4422(20)30494-4. -
Breaking newsResearchCOVID-19
The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study
April 6, 2021The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study -
Breaking newsResearchCOVID-19
Impact of the COVID‐19 pandemic on stroke teleconsultations in Germany in the first half of 2020
April 1, 2021Impact of the COVID‐19 pandemic on stroke teleconsultations in Germany in the first half of 2020 -
Breaking newsResearchCOVID-19
Impact of the COVID‐19 pandemic and a national lockdown on hospitalisation for stroke and related 30‐day mortality in France: a nationwide observational study
April 1, 2021Impact of the COVID‐19 pandemic and a national lockdown on hospitalisation for stroke and related 30‐day mortality in France: a nationwide observational study -
Breaking newsResearchCOVID-19
Outcomes and risk factors associated with SARS-CoV-2 infection in a north American registry of patients with multiple sclerosis
April 1, 2021Outcomes and risk factors associated with SARS-CoV-2 infection in a north American registry of patients with multiple sclerosis